BullScope
  • Home
  • Market News
  • Bargains & Bubbles
  • Expectations Audits
  • Research Notes
  • Said vs. Filed
  • The Economy
  • Evidence Sheets
  • Research Terminal
No Result
View All Result
SUBSCRIBE
BullScope
  • Home
  • Market News
  • Bargains & Bubbles
  • Expectations Audits
  • Research Notes
  • Said vs. Filed
  • The Economy
  • Evidence Sheets
  • Research Terminal
No Result
View All Result
BullScope
No Result
View All Result
Home Bargains & Bubbles

The Cheapest It’s Been in a Decade, at a Price No One Has Ever Paid

Moe Alsumidaie, MBA, MSF by Moe Alsumidaie, MBA, MSF
July 30, 2026
in Bargains & Bubbles
0
74
SHARES
1.2k
VIEWS
Share on XShare on LinkedInShare on Facebook

In one breath

NVIDIA’s filed numbers show a business generating nearly $50 billion in free cash flow in a single quarter, with gross margins above 74% and data center revenue nearly doubling year over year. The stock is trading at its lowest earnings multiple in a decade, sitting in the 9th percentile of its own history, by our data. Those two readings sit in direct tension, and the gap between them is the story.

Two numbers that shouldn’t share a sentence

NVIDIA’s trailing price-to-earnings ratio sits at roughly 30 times earnings as of late July 2026, according to GuruFocus data. That is the lowest it has been in a decade, near a five-year floor. In the same breath: the 10-Q filed for the quarter ended April 26, 2026 shows $81.6 billion in revenue for a single quarter, alongside operating income and free cash flow that together signal a business operating at a scale most technology companies will never approach in a full year. Free cash flow is the money left after the company pays to run and build itself, the cash that can actually be returned to shareholders or reinvested. A business generating nearly $50 billion in free cash in ninety days, priced at a multiple near its decade low: that is the tension this piece is about.

To use our framework plainly: “the math” is what the filed fundamentals justify; “the mood” is what the market is currently paying. Right now, the math is accelerating and the mood is cooling. Understanding why, and whether that gap is rational, is the only question worth asking.

How a chip company became the spine of the AI economy

Three years ago, NVIDIA was a well-regarded graphics chip maker with a side business in data centers. Then, in early 2023, every major technology company on earth discovered simultaneously that training large AI models required NVIDIA’s specific architecture, and almost nothing else would do. The stock rose more than a thousand percent in the years that followed, according to reporting aggregated by Biggo Finance, and NVIDIA briefly became the most valuable company ever measured by market capitalization, in late 2025.

BullScope TerminalWant the full evidence sheet behind pieces like this?The terminal runs the complete workup: NVIDIA and 500+ other names, on the same official data.See the evidence engine →

The product behind that run was the Hopper architecture. The product behind the current quarter is Blackwell, the successor generation, which the Q1 FY2027 earnings call transcript from May 20, 2026 describes as constituting the majority of shipments. Each product cycle has reset expectations upward. The question the market is now wrestling with is whether the next cycle, the Rubin architecture announced in early 2026, can do it again, or whether the curve is finally bending.

What the quarter actually filed

The April 2026 10-Q is worth sitting with. Data center revenue, the segment that houses AI chip sales, reached $75.2 billion for the quarter, a 92% increase from the same period a year earlier. To make that concrete: the entire data center business has roughly doubled in twelve months. Within that segment, hyperscale customers, the big cloud providers building AI infrastructure at scale, and AI cloud and enterprise customers each contributed roughly half, with AI cloud revenue within that segment more than tripling year over year according to the earnings call transcript.

Gross margin, the share of each revenue dollar left after the direct cost of making the product, held at 74.9% on a GAAP basis. That figure matters because it tells you how much pricing power the company actually has. A business keeping nearly 75 cents of every sales dollar before overhead is a business whose customers have few credible alternatives. NVIDIA’s margin has held near this level even as Blackwell ramped, which is the harder trick: new product generations usually compress margins before they expand them.

The balance sheet adds another dimension. As of the April filing, NVIDIA held substantial cash and short-term investments against long-term debt that amounts to a rounding error against its quarterly free cash flow. It is a company carrying more in liquid investments than most S&P 500 members earn in a year.

The shareholder return that changes the story

In May 2026, NVIDIA announced an additional $80 billion share repurchase authorization, according to TradingView, citing GuruFocus, bringing total available buyback capacity to roughly $119 billion. Simultaneously, the company raised its quarterly dividend meaningfully, with the first payment at the new rate made in June 2026. The company has stated a policy of returning half of free cash flow through dividends and buybacks. At the current quarterly free cash flow run rate, that is a return program larger than most technology companies’ entire annual revenue.

BullScope TerminalYou just read NVIDIA’s filed numbers.Every claim above traces to a filing. Run any of 500+ companies through the same math-vs-mood engine. Free tier available.Open the Terminal →

This matters for the math-versus-mood question because buybacks at a low multiple are arithmetically accretive: each dollar spent retiring shares buys more earnings per remaining share than the same dollar spent when the multiple was high. A company buying back stock at today’s multiple is doing something structurally different from the same company buying at the elevated multiples it carried for much of the past decade, by our data.

Where the mood is cooling, and why

The stock has pulled back from its highs even as the underlying business has continued to file record numbers. Some of that discount reflects genuine uncertainty. The Q1 FY2027 earnings call noted that forward guidance explicitly excludes data center compute revenue from China, a market closed off by export restrictions. Custom silicon programs at major hyperscalers, Google’s TPUs, Amazon’s Trainium, Microsoft’s Maia, represent a structural hedge that customers are building against NVIDIA dependency. These are real competitive developments, not hypothetical ones.

Some analysts have also flagged concerns about financing arrangements where NVIDIA may provide financial backstops to customers who then purchase its chips, a practice that MarketBeat’s analyst consensus summary notes has drawn scrutiny from credit markets. The data cannot resolve whether this is a material risk or a marginal one, and we say so plainly.

What the data can say: NVIDIA holds an estimated three-quarters or more of revenue share in AI accelerators in the first half of 2026, according to Biggo Finance’s market reporting. Losing share from that position is almost certain over time. The question is the pace, and the filings do not answer it.

Reading the numbers

  • $81.6 billion in quarterly revenue (Q1 FY2027, ended April 26, 2026, per the 10-Q). What it is: total sales in one quarter. What it means here: annualized, this run rate exceeds $320 billion, roughly half again the full-year revenue filed just twelve months earlier. Everyday anchor: if a mid-size city of 500,000 households each spent $640,000 in a year, that is roughly this number.
  • 74.9% gross margin (same filing). What it is: of every dollar of revenue, 74.9 cents remain after the direct cost of making the product. What it means here: this is among the highest sustained margins in the semiconductor industry, and it has held flat through a major product transition. Everyday anchor: a bakery keeping 75 cents of every dollar after flour and labor, before rent and salaries, would be considered extraordinary in any industry.
  • P/E ratio of roughly 30 times (trailing, as of late July 2026, per GuruFocus). What it is: the price tag per dollar of annual profit. What it means here: our data places this in the 9th percentile of NVIDIA’s own decade-long history, meaning the market has priced the stock this cheaply, relative to its own earnings, only 9% of the time over ten years. Everyday anchor: a rental property that historically sold for 90 times annual rent is now selling for 30 times the same rent, while the rent itself is rising.
  • $48.6 billion in quarterly free cash flow (Q1 FY2027, per the 10-Q). What it is: cash generated after all capital spending, available to return to shareholders or reinvest. What it means here: this single quarter’s free cash flow exceeds NVIDIA’s entire annual revenue as recently as fiscal year 2021. Everyday anchor: a household that used to earn $60,000 a year now clears $48,000 in a single month after expenses.

Sources

  • NVIDIA 10-Q, quarter ended April 26, 2026 (SEC EDGAR)
  • NVIDIA 10-K, fiscal year ended January 25, 2026 (SEC EDGAR)
  • NVIDIA Q1 FY2027 Earnings Call Transcript, May 20, 2026
  • GuruFocus: NVIDIA trailing P/E
  • GuruFocus: NVIDIA price-to-sales ratio
  • GuruFocus: NVIDIA EV/EBITDA
  • MarketBeat: NVIDIA analyst consensus and price targets
  • TradingView, citing GuruFocus: NVIDIA dividend and buyback announcement
  • Biggo Finance: NVIDIA market share and valuation history
  • 247 Wall St.: Bank of America on NVIDIA networking silicon, July 16, 2026
BullScope publishes impersonal research for a general audience. Nothing here is personalized investment advice, and nothing here is a recommendation to buy or sell any security. As of publication, neither BullScope nor its operator holds a position in any security, covered or otherwise; we do not trade at all, and we accept no compensation from any company we cover. When a conflict of interest exists, we do not publish: companies that compensate our operator in any capacity, or about which our operator could hold nonpublic information, are barred from coverage automatically, as described in the conflicts policy in our methodology. Figures come from company filings and public data through our published methodology; forecasts are conditional scenarios, not predictions and not promises. Markets carry risk, including loss of principal. Consider your own situation, or consult a licensed adviser, before acting on anything you read.
BullScope TerminalYou just read NVIDIA’s filed numbers.Every claim above traces to a filing. Run any of 500+ companies through the same math-vs-mood engine. Free tier available.Open the Terminal →
Moe Alsumidaie, MBA, MSF

Moe Alsumidaie, MBA, MSF

Moe Alsumidaie, MBA, MSF is the Chief Editor of BullScope. Trained in finance, with a Master of Science in Finance and an MBA, he spent years inside large public healthcare companies including Abbott, Genentech, and Roche, learning how the businesses behind the filings actually run. As a journalist and Chief Editor of The Clinical Trial Vanguard, his reporting has appeared in Applied Clinical Trials, The American Journal of Managed Care, and CNET, and has been cited in U.S. Supreme Court proceedings. At BullScope he brings those disciplines together: every note starts in the SEC filings, runs through published methodology, and shows its work.

Recommended For You

Halozyme: The Royalty Machine Trading at a Premium to Its Own History

by Moe Alsumidaie, MBA, MSF
September 9, 2026
0

Six years ago, Halozyme Therapeutics was a mid-sized biotech with a clever idea and a thin income statement. The idea was ENHANZE, a drug-delivery technology that dissolves the...

Read moreDetails

Merck Is Printing Money and Losing Money at the Same Time. Both Are True.

by Moe Alsumidaie, MBA, MSF
September 7, 2026
0

A trailing price-to-earnings ratio of 120 sits next to a price-to-sales ratio near its highest point in a decade. Those two numbers describe the same stock on the...

Read moreDetails

A $2.4 Billion Question: What Sarepta’s Filed Numbers Actually Say

by Moe Alsumidaie, MBA, MSF
September 3, 2026
0

The gist of it Sarepta's filed numbers tell a story of a company that briefly turned profitable in 2024, then swung back to a loss in 2025 after...

Read moreDetails

The Quiet Compounder at a Loud Price: What Royalty Pharma’s Filings Actually Say

by Moe Alsumidaie, MBA, MSF
September 2, 2026
0

Royalty Pharma's stock sat at an all-time low in December 2024. By late August 2026, it had touched an all-time high above $62. That is a gain of...

Read moreDetails

Half the Price, Same Business: What Zoetis’s Filed Numbers Actually Say

by Moe Alsumidaie, MBA, MSF
August 31, 2026
0

Two years ago, Zoetis traded at roughly 35 times its annual earnings. Today it trades at roughly 12 times. The revenue line has kept growing. The margin line...

Read moreDetails
Next Post

Evidence Sheet: NVIDIA (NVDA)

Please login to join discussion
BullScope
The Research Terminal
Run any stock through the BullScope evidence engine. Filings in, evidence out. Every number explains itself.
Open the Terminal
A BullScope product

Related News

Evidence Sheet: Moderna (MRNA)

September 3, 2026

Apple at 97th Percentile: What the Price Already Believes

August 13, 2026

Elanco Is Earning More Than It Ever Has. The Stock Is Priced Like That’s Just the Beginning.

August 27, 2026
BullScope

BullScope is an evidence-first investment research publication. Every note starts in the filings: what companies actually report, what the market assumes, and where the two disagree. We read the numbers so you can read the story. Not investment advice.

Prefer BullScope.ai on Google

© 2026 BullScope. Evidence-first investment research. Not investment advice.  ·  Methodology  ·  Privacy Policy  ·  Terms of Use  ·  Disclaimer

No Result
View All Result
  • Home
  • Market News
  • Bargains & Bubbles
  • Expectations Audits
  • Research Notes
  • Said vs. Filed
  • The Economy
  • Evidence Sheets
  • Research Terminal

© 2026 BullScope. Evidence-first investment research. Not investment advice.  ·  Methodology  ·  Privacy Policy  ·  Terms of Use  ·  Disclaimer

Not enough quota to unlock this post
Unlock left : 0
Are you sure want to cancel subscription?
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.